Results 91 to 99 of about 120,772 (99)

Characterization of the novel HLA‐DRB1*04:275 allele by sequencing‐based typing

Hla, 2020
Vincent Elsermans, Jonathan Visentin, Isabelle Top   +2 more
exaly  

Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription

Journal of Bone and Mineral Research, 2011
Ha-Neui Kim, Jong-Ho Lee, Suk-Chul Bae   +2 more
exaly  

Histone deacetylases inhibitor MS‐275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway

Journal of Cellular Physiology, 2019
Yuming Wang, Tuanjie Huang, Hongtao Liu   +2 more
exaly  

Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo

European Journal of Pharmacology, 2015
Nagaraj M Kulkarni, Shridhar Narayanan
exaly  

Molecular mechanisms associated with the antidepressant effects of the class I histone deacetylase inhibitor MS-275 in the rat ventrolateral orbital cortex

Brain Research, 2012
Huali Lin, Jianguo Shi
exaly  

Tetrandrine enhances antitumor effects of the histone deacetylase inhibitor MS-275 in human cancer in a Bax- and p53-dependent manner

European Journal of Pharmacology, 2020
exaly  

MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice

European Journal of Pharmacology, 2012
Ha-Neui Kim, Jong-Ho Lee, Won Jong Jin
exaly  

Novel Antimicrobial Indolepyrazines A and B from the Marine-Associated Acinetobacter sp. ZZ1275

Marine Drugs, 2019
Komal Anjum, Wenwen Yi, Guowan Zheng
exaly  

Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells

Leukemia Research, 2008
Claudia Miller, Jessica Boklan, Joya Chandra   +2 more
exaly